Citation Impact
Citing Papers
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
2012 Standout
Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
2011
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
2014 StandoutNobel
Pancreatic cancer
2004 Standout
Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy
2016
Management of borderline and locally advanced pancreatic cancer: Where do we stand?
2014
Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study
2019
Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients
2004
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
Altered fractionation and combined radio-chemotherapy approaches
2003
Pancreatic cancer
2020 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms
2008
FOLFIRINOX for Locally Advanced Pancreatic Adenocarcinoma: Results of an AGEO Multicenter Prospective Observational Cohort
2014
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Cancer Statistics, 2006
2006 Standout
Advanced pancreatic carcinoma: current treatment and future challenges
2010
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Pancreatic cancer
2016 Standout
Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma
2010
Gemcitabine in combination with 5-fluorouracil with or without folinic acid in the treatment of pancreatic cancer
2002
Mechanisms in Epithelial Plasticity and Metastasis: Insights from 3D Cultures and Expression Profiling
2002
Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?
2011
Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study
2016
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
Pancreatic Adenocarcinoma
2014 Standout
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
ATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks
2001 Standout
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals
2009
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas
2009
The biochemistry and medical significance of the flavonoids
2002 Standout
The golden age: gold nanoparticles for biomedicine
2011 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles
2011
Antimicrobial activity of metals: mechanisms, molecular targets and applications
2013 Standout
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Adjuvant therapy in pancreatic cancer: historical and current perspectives
2003
A study of body image in long‐term breast cancer survivors
2010 Standout
The use of gold nanoparticles to enhance radiotherapy in mice
2004 Standout
Idarucizumab for Dabigatran Reversal
2015 Standout
Heavy Metal Toxicity and the Environment
2012 Standout
Pancreatic Cancer
2010 Standout
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
The basics of epithelial-mesenchymal transition
2009 Standout
A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy
2014
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity?
1999
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study
2008
Pancreatic cancer
2011 Standout
Gemcitabine Combined With Oxaliplatin in Advanced Pancreatic Adenocarcinoma: Final Results of a GERCOR Multicenter Phase II Study
2002
Association of G 1 /S-Phase and Late S-Phase Checkpoints with Regulation of Cyclin-Dependent Kinases in Chinese Hamster Ovary Cells
1997
Effect of 6(5H)-phenanthridinone, a poly (ADP-ribose)polymerase inhibitor, and ionizing radiation on the growth of cultured lymphoma cells
1997
Lanthanide Luminescence for Biomedical Analyses and Imaging
2010 Standout
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Megawatt-scale average-power ultrashort pulses in an enhancement cavity
2014 StandoutNobel
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
2006 Standout
In Situ Imaging of Metals in Cells and Tissues
2009
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Radiotherapy enhancement with gold nanoparticles
2008
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Development of a Syngeneic Rat Brain Tumor Model Expressing EGFRvIII and Its Use for Molecular Targeting Studies with Monoclonal Antibody L8A4
2005
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
Chemoradiotherapy in the Management of Locally Advanced Pancreatic Carcinoma: A Qualitative Systematic Review
2009
Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis
2006
Drug delivery and nanoparticles: Applications and hazards
2008 Standout
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
2016
Molecular Targeting and Treatment of Composite EGFR and EGFRvIII-Positive Gliomas Using Boronated Monoclonal Antibodies
2008
Genotoxicity Studies of Heavy Metals: Lead, Bismuth, Indium, Silver and Antimony
2009
Non-planar four-mirror optical cavity for high intensity gamma ray flux production by pulsed laser beam Compton scattering off GeV-electrons
2012
Preparation of amine free silica-coated Agl nanoparticles with modified Stöber method
2008
Balancing of thermal lenses in enhancement cavities with transmissive elements
2015 StandoutNobel
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Emergence of Stereotactic Body Radiation Therapy and Its Impact on Current and Future Clinical Practice
2014
Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancer.
2003
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
Epstein-Barr Virus Encodes a Novel Homolog of thebcl-2Oncogene That Inhibits Apoptosis and Associates with Bax and Bak
1999
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Flavonoids as enhancers of x-ray-induced cell damage in hepatoma cells.
1997
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
2004
Works of Jacques Balosso being referenced
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)
2001
Irradiation in presence of iodinated contrast agent results in radiosensitization of endothelial cells: Consequences for computed tomography therapy
2005
Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds
2004
Cancer: the role of extracellular disease
2002
Monte Carlo dosimetry for synchrotron stereotactic radiotherapy of brain tumours
2005
Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study
2000
Molecular and cellular response of the most extensively used rodent glioma models to radiation and/or cisplatin
2007
Lead contamination results in late and slowly repairable DNA double-strand breaks and impacts upon the ATM-dependent signaling pathways
2007
Lack of Cell Death Enhancement after Irradiation with Monochromatic Synchrotron X Rays at the K-Shell Edge of Platinum Incorporated in Living SQ20B Human Cells ascis-Diamminedichloroplatinum (II)
2002
Total-body irradiation before bone marrow transplantation. Results of two randomized instantaneous dose rates in 157 patients
1992
Radiotherapy quality insurance by individualized in vivo dosimetry: State of the art
2009
Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy
2005
Early breast cancer: influence of type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy
1995
Angiogenèse tumorale: physiopathologie, valeur pronostique et perspectives thérapeutiques
1998
Additive and supraadditive interaction between ionizing radiation and pazelliptine, a DNA topoisomerase inhibitor, in Chinese hamster V-79 fibroblasts.
1991
DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide.
1993
Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies
2007
Cure of Fisher Rats Bearing Radioresistant F98 Glioma Treated with cis -Platinum and Irradiated with Monochromatic Synchrotron X-Rays
2004
Interaction of ionizing radiation with the topoisomerase I poison camptothecin in growing V-79 and HeLa cells.
1994
Enhanced Survival and Cure of F98 Glioma–Bearing Rats following Intracerebral Delivery of Carboplatin in Combination with Photon Irradiation
2007